Charles Cliff Duncan
CIK: 0002130896
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VNDA
Vanda Pharmaceuticals Inc.
Director
Discretionary Trading P&L
Holdings
About Duncan Charles Cliff
Duncan Charles Cliff (SEC CIK 0002130896) files insider reports with the SEC as Director of Vanda Pharmaceuticals Inc. (VNDA).
Signal8 holds 3 ownership filings by Duncan Charles Cliff (1 Form 3, 2 Form 4), filed between Apr 24, 2026 and Jun 8, 2026. Those filings report 2 transactions, from Apr 22, 2026 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Duncan Charles Cliff's filings is in WASHINGTON, DC.
Recent filings by Duncan Charles Cliff
Other insiders filing for Vanda Pharmaceuticals Inc. (VNDA)
- McGuire Daniel Patrick, SVP, GC and Secretary
- Chrousos Phaedra, Director
- DUGAN RICHARD W, Director
- Ward Anne Sempowski, Director
- Honore Tage, Director
- Mitchell Stephen Ray, Director